Literature DB >> 7215068

Correlation between decreased heart rate and central inhibition of sympathetic discharge after prazosin administration in the spontaneously hypertensive rat.

B Persson, T Yao, P Thorén.   

Abstract

Mean arterial blood pressure, heart rate and splanchnic sympathetic discharge were recorded in conscious and anaesthetized spontaneously hypertensive rats (SHR). Administration of prazosin (1 mg/kg i.v.) reduced heart rate in most rats and this effect was closely parallelled by a decrease in sympathetic discharge. In contrast, administration of hydralazine (1 mg/kg i.v.) caused a sustained tachycardia and increased sympathetic nervous activity. The cardiovascular effects of prazosin (0.2-0.3, 1 and 3 mg/kg i.v.) were examined in different rat strains. Sprague-Dawley and Wistar-Kyoto rats responded with tachycardia whereas a significant bradycardia was observed in SHR following the higher doses of prazosin. It is suggested that the bradycardia obtained after prazosin administration is due to a central inhibition of sympathetic outflow, an effect possibly caused by blockade of alpha-adrenoreceptors. The different heart rate responses in different rat strains may be interpreted to reflect differences in sensitivity of central alpha-adrenoreceptors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7215068     DOI: 10.3109/10641968109033663

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 0148-3927            Impact factor:   1.749


  3 in total

1.  Haemodynamic effects of dicentrine, a novel alpha 1-adrenoceptor antagonist: comparison with prazosin in spontaneously hypertensive and normotensive Wistar-Kyoto rats.

Authors:  S M Yu; S Y Hsu; F N Ko; C C Chen; Y L Huang; T F Huang; C M Teng
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

2.  The mechanism of the sympathoinhibitory action of urapidil: role of 5-HT1A receptors.

Authors:  A G Ramage
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

3.  Investigation into the cardioregulatory properties of the alpha 1-adrenoceptor blocker indoramin.

Authors:  V Pierce; N B Shepperson; M H Todd; J F Waterfall
Journal:  Br J Pharmacol       Date:  1986-02       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.